Can Rosuvastatin Reduce the Risk of Thrombosis in Patients with Hypercholesterolemia with its Effect on Coagulation Factors and Homocysteine Levels?

Mostafa BehnamMohammad Reza DeyhimParichehreh Yaghmaei

Published in: Cardiovascular & hematological agents in medicinal chemistry (2024)

According to the results, it seems that rosuvastatin may be able to reduce the risk of thrombosis in patients by affecting coagulation factors and homocysteine levels.

Keyphrases

end stage renal disease
pulmonary embolism
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
type diabetes
cardiovascular disease
patient reported outcomes